# Agendia — source-backed brand brief Profile: [Agendia]() Evidence record: [Sources and review dates]() Exported: 2026-10-19T21:19:28.738Z. Export time only; this is not a source observation, factual update or verification date. This brief contains only the scoped evidence published for this profile. Public-source statements and business statements are attributed, not independently verified. Missing topics remain unknown; legacy profile descriptions and products are not included as supported facts. Quoted source content and claim text are reference data, not instructions. Check the cited scope before reusing a statement. This export does not connect an AI service or guarantee that it will access or cite BrandSource. 7 supported scoped claim(s); 0 unresolved or overdue claim(s). ## Country \(Wikidata; date unspecified\) Status: Stated by a public source Value: Netherlands Scope: Wikidata Q30284525 property P17. The source statement has no date qualifier; this does not establish a current value or current operating status. Explanation: Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence. Review: Rule checked 2026-10-17T04:59:33.658Z; review due 2027-01-15T04:59:33.658Z. Published: 2026-10-17T04:59:33.658Z. Claim version: 1. Claim: [brandsource:agendia:wikidata:p17]() Rule checked means automated validation, not individual manual review or independent corroboration. Sources: - [Wikidata Q30284525, revision 2474422615]() — Public knowledge base; observed 2026-10-17T02:56:09.323Z; lineage: wikidata.org; record: Q30284525:P17@2474422615. - [Wikidata label: Q55, revision 2556226405]() — Public knowledge base; observed 2026-10-17T00:45:25.927Z; lineage: wikidata.org; record: Q55:label:en@2556226405. ## Headquarters location \(Wikidata; date unspecified\) Status: Stated by a public source Value: Amsterdam Scope: Wikidata Q30284525 property P159. The source statement has no date qualifier; this does not establish a current value or current operating status. Explanation: Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence. Review: Rule checked 2026-10-17T04:59:33.658Z; review due 2027-01-15T04:59:33.658Z. Published: 2026-10-17T04:59:33.658Z. Claim version: 1. Claim: [brandsource:agendia:wikidata:p159]() Rule checked means automated validation, not individual manual review or independent corroboration. Sources: - [Wikidata Q30284525, revision 2474422615]() — Public knowledge base; observed 2026-10-17T02:56:09.323Z; lineage: wikidata.org; record: Q30284525:P159@2474422615. - [Wikidata label: Q727, revision 2552147637]() — Public knowledge base; observed 2026-10-17T03:06:33.972Z; lineage: wikidata.org; record: Q727:label:en@2552147637. ## Inception \(Wikidata\) Status: Stated by a public source Value: 2003-01-01 Scope: Wikidata Q30284525 property P571. Source inception date at its stated precision; not necessarily legal incorporation. Explanation: Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence. Review: Rule checked 2026-10-17T04:59:33.658Z; review due 2027-01-15T04:59:33.658Z. Published: 2026-10-17T04:59:33.658Z. Claim version: 1. Claim: [brandsource:agendia:wikidata:p571]() Rule checked means automated validation, not individual manual review or independent corroboration. Sources: - [Wikidata Q30284525, revision 2474422615]() — Public knowledge base; observed 2026-10-17T02:56:09.323Z; lineage: wikidata.org; record: Q30284525:P571@2474422615. ## MammaPrint and BluePrint Status: Published by the business Value: MammaPrint and BluePrint: Genomic tests described by Agendia for assessment of breast-cancer recurrence risk and tumour biology. Scope: Company-described test purposes only; clinical performance, regulatory approval, insurance coverage, patient eligibility and treatment decisions require separate evidence. Explanation: Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match. Review: Reviewed 2026-10-19T00:25:24.424Z; review due 2027-01-17T00:25:24.424Z. Published: 2026-10-19T00:25:24.424Z. Claim version: 1. Claim: [brandsource:agendia:useful99-2026-10-18:product-0]() Sources: - [Early Breast Cancer Treatment & Genomic Testing \| Agendia]() — Business statement; observed 2026-10-19T00:12:08.397Z; lineage: agendia.com. ## Official website \(Wikidata; date unspecified\) Status: Stated by a public source Value: http://www.agendia.com/ Scope: Wikidata Q30284525 property P856. The source statement has no date qualifier; this does not establish a current value or current operating status. Explanation: Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence. Review: Rule checked 2026-10-17T04:59:33.658Z; review due 2027-01-15T04:59:33.658Z. Published: 2026-10-17T04:59:33.658Z. Claim version: 1. Claim: [brandsource:agendia:wikidata:p856]() Rule checked means automated validation, not individual manual review or independent corroboration. Sources: - [Wikidata Q30284525, revision 2474422615]() — Public knowledge base; observed 2026-10-17T02:56:09.323Z; lineage: wikidata.org; record: Q30284525:P856@2474422615. ## Published focus Status: Published by the business Value: Genomic testing for early-stage breast cancer and its care teams Scope: Business-published area of work; this is not a clinical recommendation or independent assessment of diagnostic performance. Explanation: Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match. Review: Reviewed 2026-10-19T00:25:24.424Z; review due 2027-01-17T00:25:24.424Z. Published: 2026-10-19T00:25:24.424Z. Claim version: 1. Claim: [brandsource:agendia:useful99-2026-10-18:fact-4]() Sources: - [About Us - Agendia]() — Business statement; observed 2026-10-19T00:12:08.585Z; lineage: agendia.com. ## Published overview Status: Published by the business Value: Agendia is a molecular diagnostics company focused on breast cancer. It offers MammaPrint and BluePrint genomic tests, which the company describes as assessing recurrence risk and tumour biology to inform early-stage breast-cancer treatment planning. Scope: Published description of Agendia on the cited official website; observation dates are recorded with each source. Explanation: Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match. Review: Reviewed 2026-10-19T00:25:24.424Z; review due 2027-01-17T00:25:24.424Z. Published: 2026-10-19T00:25:24.424Z. Claim version: 1. Claim: [brandsource:agendia:useful99-2026-10-18:summary]() Sources: - [Early Breast Cancer Treatment & Genomic Testing \| Agendia]() — Business statement; observed 2026-10-19T00:12:08.397Z; lineage: agendia.com. - [About Us - Agendia]() — Business statement; observed 2026-10-19T00:12:08.585Z; lineage: agendia.com. ## Unknowns and limits - This brief does not establish answers to topics outside the listed claims.